✦ LIBER ✦

Serum C-reactive protein is a useful biomarker for predicting outcomes after liver transplantation in patients with hepatocellular carcinoma

✍ Scribed by An, Ho Jung; Jang, Jeong Won; Bae, Si Hyun; Choi, Jong Young; Yoon, Seung Kew; Lee, Myung Ah; You, Young Kyoung; Kim, Dong Goo; Jung, Eun Sun

Book ID: 118763895
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 292 KB
Volume: 18
Category: Article
ISSN: 1527-6465
DOI: 10.1002/lt.23512

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Outcomes of Liver Transplantation in 490

Outcomes of Liver Transplantation in 490 Patients with Hepatocellular Carcinoma: Validation of a Uniform Staging after Surgical Treatment

✍ Jean-Nicolas Vauthey; Dario Ribero; Eddie K. Abdalla; Sven Jonas; Ankit Bharat; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 470 KB

221 IS EXPANDING MILAN CRITERIA SAFE? US

221 IS EXPANDING MILAN CRITERIA SAFE? USE OF EXPANDED CRITERIA FOR LIVER TRANSPLANT DOES NOT SIGNIFICANTLY DECREASE OUTCOMES IN PATIENTS WITH HEPATOCELLULAR CARCINOMA

✍ Q. Lai; A. Avolio; G. Tisone; A. Molinaro; F. Melandro; S. Agnes; P.B. Berloco; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 48 KB

Paclitaxel promotes liver graft survival

Paclitaxel promotes liver graft survival in rats and inhibits hepatocellular carcinoma growth in vitro and is a potentially useful drug for transplant patients with liver cancer

✍ I Iesalnieks; S Tange; M.N Scherer; C Graeb; E Frank; K.W Jauch; E.K Geissler 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 49 KB

Serum insulin-like growth factor I evalu

Serum insulin-like growth factor I evaluation as a useful tool for predicting the risk of developing hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis : A prospective study

✍ Gherardo Mazziotti; Francesca Sorvillo; Filomena Morisco; Antonella Carbone; Mar 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 108 KB 👁 3 views

## Background: Although experimental studies have demonstrated an important role of insulin-like growth factor i (igf-i) in hepatocarcinogenesis, the clinical data about igf-i in patients with hepatocellular carcinoma (hcc) are scarce and controversial. to the authors' knowledge, this is the first